Replies to post #809535 on NorthWest Biotherapeutics Inc (NWBO)

[10baggerz]

Great post/question. As usual I'm sure it's multifactorial. Just off the top of my head:Time-elapsed since start of trials, company finanances preventing pre-approval PR blitzes, quality and connections of investor relations, lack of perception that dendritic cells are cutting edge technologies, lack of respect of a company trading on the OTC, LP's lack of social skills and social media presence, the fact that management are all introverted lawyers not salespeople, the fact that they chose one of the rarest cancers to do a PIII trial and have not initiated any trials since so the public interest is exponentially less in GBM alone, etc.

[Doc logic]

Survivir2012,

Media coverage is limited based likely on two things. The first is that Fox News carried a piece years ago then found out that nothing was really on the horizon. Not a peep since. There was an analyst group that had forecast 2018 as a pivotal year for NWBO. Whoops! Bottom line is there is no reason to expect big media coverage on something that has an indeterminate time frame for becoming a reality.
The second reason is that big pharma pays for a great deal of advertising on the major media outlets. No one wants to upset the gravy train when NWBO can’t come close to replacing that revenue which might be lost because of NWBO. Best wishes.

[learningcurve2020]

I’d make sense the Invisible Woman runs an invisible company.

[jtaylor042]

Wasn't there an hour long interview with Drs. Toms & Elinzano post publication?

[manibiotech]

" Thoughts, reasonsfor no coverage by national or international media?"
I think you should direct this question to the management and especially the IR department who have been drawing salary for years .

[Investor082]

Because no one cares about dendritic cell product/tech. Even Roswell Park didn’t get any interest in their DC vaccine work and therefore ended up selling pennies on dollar to NWBO.

Besides, NWBO execs have done nothing but lost investor money over the last 15+ years. Two generation wiped off, over 99% loss in value. NWBO takes money from shady financiers and there are no institutional investors. In short, no credibility in media and investment circles.

5+ years since data lock and only one application submitted so far. And that too is stuck for 2+ years and more importantly no reimbursement evidence submission. Furthermore, no FDA submission 5+ years since data lock.

Why would anyone take this company seriously? It’s a dilution scam that consistently set false expectations around milestones to trap bag holders! ;)

[QL300]

I think the simplest reason it doesn't have a "wow" factor. Most of the publicity is directed at new trials that are supposed cures for cancer. While some people are cured, this is more like an improvement. Five year survival has more than doubled, it's shown to be effective but survival is still pretty low. I could see some publicity when the combo results with Keytruda come in showing 60%-70%+ survival. Even with MHRA approval, I doubt a lot of media will be covering this.